ProQR Therapeutics (PRQR) Accounts Payables (2021 - 2024)
Historic Accounts Payables for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $17097.5.
- ProQR Therapeutics' Accounts Payables fell 9896.88% to $17097.5 in Q4 2024 from the same period last year, while for Dec 2024 it was $17097.5, marking a year-over-year decrease of 9896.88%. This contributed to the annual value of $17317.4 for FY2024, which is 9896.11% down from last year.
- Per ProQR Therapeutics' latest filing, its Accounts Payables stood at $17097.5 for Q4 2024, which was down 9896.88% from $1.7 million recorded in Q4 2023.
- In the past 5 years, ProQR Therapeutics' Accounts Payables registered a high of $1.7 million during Q4 2023, and its lowest value of $331.71 during Q1 2021.
- For the 4-year period, ProQR Therapeutics' Accounts Payables averaged around $492730.4, with its median value being $332378.9 (2021).
- As far as peak fluctuations go, ProQR Therapeutics' Accounts Payables skyrocketed by 27869549.4% in 2022, and later crashed by 9896.88% in 2024.
- Quarter analysis of 4 years shows ProQR Therapeutics' Accounts Payables stood at $218498.5 in 2021, then skyrocketed by 83.04% to $399936.9 in 2022, then surged by 314.57% to $1.7 million in 2023, then crashed by 98.97% to $17097.5 in 2024.
- Its Accounts Payables was $17097.5 in Q4 2024, compared to $1.7 million in Q4 2023 and $127365.1 in Q3 2023.